Curaleaf Holdings (CURLF) Short term Debt (2019 - 2024)
Curaleaf Holdings (CURLF) posted quarterly Short term Debt of $3.3 million for Q4 2024, down 72.19% year-on-year from $11.9 million in Q1 2024, and down 42.06% on a QoQ basis from $5.7 million in Q3 2024.
Curaleaf Holdings (CURLF) Short term Debt (2019 - 2024) Analysis & Trends
Curaleaf Holdings (CURLF) has reported Short term Debt for 6 consecutive years, with $3.3 million the latest figure, recorded in Q4 2024.
- Quarterly Short term Debt fell 72.19% year-over-year to $3.3 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $3.3 million (down 72.19% YoY) and the FY2024 annual result came in at $3.3 million, down 72.19% from the prior year.
- Short term Debt eased to $3.3 million in Q4 2024 per CURLF's latest filing, from $5.7 million in the prior quarter.
- Over the last five years, Short term Debt for CURLF reached as high as $28.8 billion in Q1 2022 and fell as low as $3.3 million in Q4 2024.
- A 5-year average of $1.8 billion and a median of $9.7 million in 2020 frame the typical range for Short term Debt.
- Annual changes were most pronounced in 2022 — Short term Debt soared 686926.0% — and 2024, when it slumped 90.82%.
- Year by year, Short term Debt stood at $6.5 million in 2020, then soared by 40.85% to $9.2 million in 2021, then soared by 102.49% to $18.5 million in 2022, then slumped by 35.8% to $11.9 million in 2023, then tumbled by 72.19% to $3.3 million in 2024.
- According to Business Quant data, Short term Debt over the past three periods registered $3.3 million, $5.7 million, and $9.7 million for Q4 2024, Q3 2024, and Q2 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Curaleaf Holdings | 7.13 Bn | 7.13 Bn | 157.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 3.31 Mn |
| Sep 30, 2024 | 5.71 Mn |
| Jun 30, 2024 | 9.67 Mn |
| Dec 31, 2023 | 11.90 Mn |
| Sep 30, 2023 | 62.25 Mn |
| Jun 30, 2023 | 48.47 Mn |
| Dec 31, 2022 | 18.54 Mn |
| Sep 30, 2022 | 23.48 Mn |
| Jun 30, 2022 | 20.96 Mn |
| Mar 31, 2022 | 28.81 Bn |
| Dec 31, 2021 | 9.16 Mn |
| Sep 30, 2021 | 9.16 Mn |
| Jun 30, 2021 | 9.16 Mn |
| Mar 31, 2021 | 4.19 Mn |
| Dec 31, 2020 | 6.50 Mn |
| Sep 30, 2020 | 9.70 Mn |
| Dec 31, 2019 | 17.00 Mn |